{
    "2020-05-19": [
        [
            {
                "time": "",
                "original_text": "医药生物行业日报：医药高位震荡格局延续",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "高位震荡"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【华西医药崔文亮团队】《医药生物行业点评报告：两会医药议题解读：疫苗、创新药、IVD和医疗设备等领域继续成为关注焦点》",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "两会",
                        "疫苗",
                        "创新药",
                        "IVD",
                        "医疗设备"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物",
                        "疫苗",
                        "创新药",
                        "IVD",
                        "医疗设备"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}